Business Description
NeoGenomics Inc
NAICS : 541714
SIC : 8734
Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | -6.93 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.03 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.3 | |||||
| 3-Year Book Growth Rate | 17.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.35 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.39 | |||||
| 9-Day RSI | 50.62 | |||||
| 14-Day RSI | 54.42 | |||||
| 6-1 Month Momentum % | 94.57 | |||||
| 12-1 Month Momentum % | 34.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.73 | |||||
| Quick Ratio | 6.46 | |||||
| Cash Ratio | 4.87 | |||||
| Days Inventory | 26.58 | |||||
| Days Sales Outstanding | 81.05 | |||||
| Days Payable | 20.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.86 | |||||
| Operating Margin % | -30.04 | |||||
| Net Margin % | -28.3 | |||||
| ROE % | -13.77 | |||||
| ROA % | -8.03 | |||||
| ROIC % | -10.72 | |||||
| ROC (Joel Greenblatt) % | -53.82 | |||||
| ROCE % | -9.21 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.33 | |||||
| PB Ratio | 2.26 | |||||
| Price-to-Tangible-Book | 33.48 | |||||
| EV-to-EBIT | -15.3 | |||||
| EV-to-EBITDA | -27.35 | |||||
| EV-to-Revenue | 4.73 | |||||
| EV-to-Forward-Revenue | 2.49 | |||||
| EV-to-FCF | -24.91 | |||||
| Price-to-Projected-FCF | 4.42 | |||||
| Price-to-Median-PS-Value | 1.14 | |||||
| Earnings Yield (Greenblatt) % | -6.54 | |||||
| Forward Rate of Return (Yacktman) % | -8.76 |
How NeoGenomics Inc (NEO) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NEO
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
NeoGenomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 509.728 | ||
| EPS (TTM) ($) | -1.16 | ||
| Beta | 1.13 | ||
| Volatility % | 96.38 | ||
| 14-Day RSI | 54.42 | ||
| 14-Day ATR ($) | 0.961647 | ||
| 20-Day SMA ($) | 17.947 | ||
| 12-1 Month Momentum % | 34.91 | ||
| 52-Week Range ($) | 6 - 19.51 | ||
| Shares Outstanding (Mil) | 127.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NeoGenomics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
NeoGenomics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NeoGenomics Inc Frequently Asked Questions
What is NeoGenomics Inc(NEO)'s stock price today?
The current price of NEO is $17.75. The 52 week high of NEO is $19.51 and 52 week low is $6.00.
When is next earnings date of NeoGenomics Inc(NEO)?
The next earnings date of NeoGenomics Inc(NEO) is 2023-04-27 Est..
Does NeoGenomics Inc(NEO) pay dividends? If so, how much?
NeoGenomics Inc(NEO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
